Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong.

[1]  R. Yolken,et al.  Manual of Clinical Microbiology, 8th Edition . , 2004 .

[2]  J. Garcia-Aymerich,et al.  Bacterial infection in exacerbated COPD with changes in sputum characteristics , 2003, Epidemiology and Infection.

[3]  E. Wouters,et al.  Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study. , 2003, Respiratory medicine.

[4]  J. Wedzicha,et al.  COPD exacerbations: definitions and classifications , 2003, European Respiratory Journal.

[5]  A. Gillissen,et al.  Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study , 2003, Thorax.

[6]  T. Seemungal,et al.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.

[7]  T. Seemungal,et al.  Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations , 2002, Thorax.

[8]  M. Miravitlles.  Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? , 2002, European Respiratory Journal.

[9]  W. Bailey,et al.  Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.

[10]  K. Dooley,et al.  Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Christine Jenkins,et al.  GOLD SCIENTIFIC COMMITTEE. GLOBAL STRATEGY FOR THE DIAGNOSIS, MANAGEMENT, AND PREVENTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. NHLBI/WHO GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (COLD) WORKSHOP SUMMARY , 2001 .

[12]  L. Davies,et al.  Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial , 1999, The Lancet.

[13]  M. Miravitlles,et al.  Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. , 1999, Chest.

[14]  D. Niewoehner,et al.  Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. , 1999, The New England journal of medicine.

[15]  T. Seemungal,et al.  Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[16]  M. Woodhead,et al.  Antibiotic use in patients admitted with acute exacerbations of chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[17]  J. Wedzicha,et al.  An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease. ISOLDE Study Group. , 1999, Respiratory medicine.

[18]  M. Rossman.  Colonization with Mycobacterium avium complex--an outdated concept. , 1999, The European respiratory journal.

[19]  A. Torres,et al.  Severe community-acquired pneumonia. , 1996, Clinics in chest medicine.

[20]  T. Ishida,et al.  Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. , 1998, Chest.

[21]  M. Niederman,et al.  Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. , 1998, Chest.

[22]  R. Rodríguez-Roisín,et al.  Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. , 1998, American journal of respiratory and critical care medicine.

[23]  T. Seemungal,et al.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[24]  L Goldman,et al.  Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.

[25]  J. Bartlett,et al.  Community-acquired pneumonia. , 2013, The New England journal of medicine.

[26]  J. Woo,et al.  Respiratory symptoms in elderly Chinese living in Hong Kong. , 1995, The European respiratory journal.

[27]  J. Ruiz,et al.  Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. , 1995, American journal of respiratory and critical care medicine.

[28]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[29]  S. Chevret,et al.  Severe Community-Acquired Pneumonia: Etiology, Epidemiology, and Prognosis Factors , 1994 .

[30]  T. Schaberg,et al.  Diagnostic problems in lower respiratory tract infections. , 1993, The Journal of antimicrobial chemotherapy.

[31]  T. Murphy,et al.  Bacterial infection in chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.

[32]  C. Chan,et al.  A prospective study of community-acquired pneumonia in Hong Kong. , 1992, Chest.

[33]  R. Rodríguez-Roisín,et al.  Severe community-acquired pneumonia. Epidemiology and prognostic factors. , 1991, The American review of respiratory disease.

[34]  N. Anthonisen,et al.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.

[35]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .

[36]  Murray Pr,et al.  Microscopic and baceriologic analysis of expectorated sputum. , 1975 .